CYTK 241115 65.00P (CYTK241115P65000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CYTK241115P65000

Watchlist

13.72
0.000.00%

15min DelayTrading Aug 12 10:08 ET

0.00High0.00Low

Intraday

5D
Daily

News

Earnings Preview: Cytokinetics to Report Financial Results Post-market on November 06
Moomoo NewsOct 31 21:00 ET
Express News | Cytokinetics to Announce Third Quarter Results on November 6, 2024
ReutersOct 23 16:00 ET
B.Riley Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $92
Moomoo NewsOct 23 08:31 ET · Ratings
Possible Bearish Signals With Cytokinetics Insiders Disposing Stock
Simply Wall StOct 22 09:28 ET
Oppenheimer Buy-rated Ideas: BSX, MDT, and One Hold: CYTK
Seeking AlphaOct 18 11:21 ET
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $72 to $120
Moomoo NewsOct 18 09:00 ET · Ratings

Comments

Mr Long Term

Aug 13 17:42

Columns Top Calls on Wall Street: Starbucks, Dell, Warner Bros. and More.

Top 5 Upgrades:
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...